Every year in the Russian Federation hundreds of billions of rubles are spent on the purchase of drugs for the treatment of patients with cancer, but the influence of the dynamics of the cost of drugs on the amount of money spent on their purchase has not been studied in our country. This was the purpose of this work. We studied the cost of drugs in 2019 and 2022. We compared the amounts of funds spent on their purchases in the Russian Federation and in the federal districts.
No takes yet. Share an insight, caveat, or question.
Linnik et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: